Genital herpes is one of the most common sexually transmitted infections in the world. About 12% of Americans aged 14 to 49 carry HSV-2, the virus most associated with genital herpes, and globally an estimated 520 million people in the same age range are infected. Those numbers only capture part of the picture, because more than 80% of people with HSV-2 either have no symptoms, have symptoms too mild to notice, or get misdiagnosed.
Prevalence in the United States
National survey data from the CDC puts HSV-2 prevalence at 11.9% among Americans aged 14 to 49. That means roughly 1 in 8 people in that age range carry the virus. The true number of genital herpes cases is higher, though, because HSV-1, the virus traditionally associated with oral cold sores, now causes a growing share of genital infections. In the U.S. and other high-income countries, HSV-1 has become the leading cause of first-episode genital herpes among adolescents and young adults.
This shift matters because standard prevalence statistics focus almost entirely on HSV-2. When you factor in genital HSV-1 infections, the real rate of genital herpes is substantially higher than the commonly cited 12%.
Global Numbers
The World Health Organization estimates that 520 million people aged 15 to 49 worldwide have HSV-2, representing about 13% of the global population in that range. Rates vary significantly by region. Sub-Saharan Africa has the highest prevalence, while parts of East Asia have some of the lowest. Across most developed regions, genital HSV-1 infections are rising by 1 to 2% annually, even as overall HSV-1 oral infection rates decline. Fewer people are catching HSV-1 as children through casual contact, which leaves them susceptible to catching it genitally through sexual contact later in life.
Why Most People Don’t Know They Have It
The single most important thing to understand about genital herpes prevalence is that the vast majority of carriers are unaware. More than 80% of HSV-2 infections are either completely asymptomatic, produce symptoms subtle enough to go unnoticed, or get mistaken for something else because the expected genital ulcers never appear. A person might experience mild irritation, a small crack in the skin, or brief itching that resolves on its own and never gets investigated.
This is also why the CDC does not recommend routine herpes blood testing for people without symptoms. Current blood tests for herpes are less precise than tests for infections like chlamydia or gonorrhea, and the risk of a false positive result is meaningfully higher, especially in people at low risk. A wrong result can cause significant emotional distress without a clear clinical benefit. Testing is generally reserved for people who have active symptoms, have a partner with known herpes, or specifically request it.
Who Is Most Affected
Genital herpes does not affect all groups equally. Women are more likely to carry HSV-2 than men. One analysis of U.S. data found a prevalence of about 21% in women compared to roughly 12% in men. This gap is largely biological: the anatomy of vaginal and vulvar tissue makes viral transmission from a male partner more efficient than the reverse.
Prevalence also increases with age. Because HSV-2 is a lifelong infection and exposure accumulates over time, rates are lowest in teenagers and climb steadily through the 30s and 40s. A 45-year-old is far more likely to test positive than a 20-year-old, simply because they’ve had more years of potential exposure.
Transmission Risk Between Partners
For couples where one partner has symptomatic, recurring genital HSV-2 and the other does not, the annual risk of transmission depends on the direction. When the male partner is the carrier, the uninfected female partner faces an 11 to 17% chance of catching the virus over the course of a year. When the female partner is the carrier, the annual risk to the male partner drops to about 3 to 4%.
These numbers come from studies of couples who knew about the infection and were not consistently using preventive measures like condoms or antiviral medication. Both of those tools reduce transmission risk significantly. Daily antiviral therapy cuts the chance of passing the virus roughly in half, and consistent condom use reduces it further, though not completely, because herpes can spread from skin not covered by a condom.
The HSV-1 Shift in Genital Herpes
For decades, genital herpes was nearly synonymous with HSV-2. That’s no longer the case. In several high-income countries across North America and Western Europe, HSV-1 has overtaken HSV-2 as the primary cause of first-episode genital herpes, particularly among young people. The mechanism is straightforward: oral-to-genital contact transmits HSV-1 to the genitals.
Genital HSV-1 behaves differently than genital HSV-2 in a few practical ways. It tends to recur less frequently, with many people experiencing only one or two outbreaks before the virus goes largely dormant. It also sheds asymptomatically less often, which likely makes it less transmissible over time. Still, a first outbreak of genital HSV-1 can be just as painful and disruptive as one caused by HSV-2.
This epidemiological shift makes it harder to track true genital herpes rates, since most large-scale surveys measure HSV-1 and HSV-2 antibodies in the blood without determining where on the body the infection is located. A person who tests positive for HSV-1 might have oral herpes, genital herpes, or both, and the blood test alone cannot distinguish between them.